Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway
- PMID: 15239102
- DOI: 10.1002/hep.20283
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a serious health problem. Although NAFLD represents a form of lipotoxicity, its pathogenesis remains poorly understood. The aim of this study was to examine the cellular mechanisms involved in free fatty acid (FFA)-mediated hepatic lipotoxicity. FFA treatment of liver cells resulted in Bax translocation to lysosomes and lysosomal destabilization with release of cathepsin B (ctsb), a lysosomal cysteine protease, into the cytosol. This process was also partially dependent on ctsb. Lysosomal destabilization resulted in nuclear factor kappa B-dependent tumor necrosis factor alpha expression. Release of ctsb into the cytoplasm was also observed in humans with NAFLD and correlated with disease severity. In a dietary murine model of NAFLD, either genetic or pharmacological inactivation of ctsb protected against development of hepatic steatosis, liver injury, and insulin resistance with its associated "dysmetabolic syndrome." In conclusion, these data support a lipotoxic model of FFA-mediated lysosomal destabilization.
Similar articles
-
[Research of Herba Artemisiae Scoporiae inhibits the hepatic lipotoxicity].Zhongguo Zhong Yao Za Zhi. 2009 Sep;34(18):2373-8. Zhongguo Zhong Yao Za Zhi. 2009. PMID: 20030092 Chinese.
-
TNF-alpha-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent.Am J Physiol Gastrointest Liver Physiol. 2004 Aug;287(2):G436-43. doi: 10.1152/ajpgi.00019.2004. Epub 2004 Apr 8. Am J Physiol Gastrointest Liver Physiol. 2004. PMID: 15075251
-
Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent.Am J Physiol Gastrointest Liver Physiol. 2002 Oct;283(4):G947-56. doi: 10.1152/ajpgi.00151.2002. Am J Physiol Gastrointest Liver Physiol. 2002. PMID: 12223355
-
Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease.Clin Liver Dis. 2004 Aug;8(3):619-38, x. doi: 10.1016/j.cld.2004.04.012. Clin Liver Dis. 2004. PMID: 15331067 Review.
-
Mechanisms of resistance to TRAIL-induced apoptosis in cancer.Cancer Gene Ther. 2005 Mar;12(3):228-37. doi: 10.1038/sj.cgt.7700792. Cancer Gene Ther. 2005. PMID: 15550937 Review.
Cited by
-
Hepatoprotective effects of magnolol in fatty liver hemorrhagic syndrome hens through shaping gut microbiota and tryptophan metabolic profile.J Anim Sci Biotechnol. 2024 Sep 6;15(1):120. doi: 10.1186/s40104-024-01074-9. J Anim Sci Biotechnol. 2024. PMID: 39238062 Free PMC article.
-
Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India.PLoS One. 2013;8(1):e49286. doi: 10.1371/journal.pone.0049286. Epub 2013 Jan 11. PLoS One. 2013. PMID: 23326306 Free PMC article.
-
A metabolomics cell-based approach for anticipating and investigating drug-induced liver injury.Sci Rep. 2016 Jun 6;6:27239. doi: 10.1038/srep27239. Sci Rep. 2016. PMID: 27265840 Free PMC article.
-
Stem cell transplantation upregulates Sirt1 and antioxidant expression, ameliorating fatty liver in type 2 diabetic mice.Int J Biol Sci. 2015 Mar 19;11(4):472-81. doi: 10.7150/ijbs.10809. eCollection 2015. Int J Biol Sci. 2015. PMID: 25798066 Free PMC article.
-
Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD.J Clin Endocrinol Metab. 2012 Jul;97(7):E1088-98. doi: 10.1210/jc.2012-1370. Epub 2012 Apr 27. J Clin Endocrinol Metab. 2012. PMID: 22544914 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous